ROBIN SHERRINGTON 4
4 · Xenon Pharmaceuticals Inc. · Filed Mar 12, 2024
Insider Transaction Report
Form 4
ROBIN SHERRINGTON
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2024-03-11+65,000→ 65,000 totalExercise: $44.37Exp: 2034-03-10→ Common Shares (65,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on January 1, 2025, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.